Findings accepted for publication in the official journal of the American College of Allergy, Asthma and Immunology About 9 out of every 10 patients experiencing anaphylaxis were effectively treated ...

SAN DIEGO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves ...

Credit: ARS Pharmaceuticals. Neffy is indicated for adult and pediatric patients weighing at least 30kg. It is recommended that patients be prescribed and have immediate access to 2 neffy nasal sprays ...

In a pivotal development this year, the U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) in August 2024 for emergency use in type 1 allergic reactions, such as anaphylaxis.

INDIANAPOLIS (WISH) — There’s a new emergency treatment for severe allergic reactions that doesn’t involve a needle. It’s called Neffy and it’s an epinephrine nasal spray. Epinephrine is the only life ...

FDA approves Neffy 1 mg for children aged 4+ weighing 15 to <30 kg for allergic reactions. Most insured patients can access Neffy for $25, while cash price is $199 for two doses. Get our list of 10 ...

Approximately five months after launch, the inclusion of neffy on these three additional formularies has expanded access to half of all patients and caregivers managing Type 1 allergic reactions, ...

The availability of neffy 1 mg extends protection to younger, school-aged children—who make up nearly 23% of people needing epinephrine Visit neffy.com for savings and support programs and pay as ...

Please provide your email address to receive an email when new articles are posted on . 4 million children in the United States have a food allergy. The neffyinSchools program provides four free doses ...

ARS Pharmaceuticals has announced a new agreement with ALK-Abelló A/S to co-promote neffy® (epinephrine nasal spray), an important treatment for severe allergic reactions, to almost 9,000 ...